Related Experiment Video
Updated: May 20, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
[Increased INR from concomitant use of acenocoumarol and capecitabine]
Ben Tomlow1, Marsha L Voll, Carolien H Smorenburg
1Medisch Centrum Alkmaar, Afd. Interne Geneeskunde, the Netherlands. B.Tomlow@mca.nl
Background:
A drug interaction between capecitabine and coumarin may result in an increased INR and bleeding complications.
Case Description:
We describe an 80-year-old woman who presented with rectal bleeding and an increased INR due to the concomitant use of acenocoumarol and capecitabine for atrial fibrillation and metastatic cecal cancer, respectively.
Conclusion:
In patients with a compelling indication for treatment with capecitabine and anticoagulant therapy, conversion to low-molecular weight heparin should be considered.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics: Drug–Drug Interactions
Drug toxicity: Drug–Drug Interaction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...